Molecular-targeted approach to cancer therapy -: The roles of P53 and P21WAF1/CIP1 genes

被引:0
作者
Kralj, Marijeta [1 ]
机构
[1] Rudjer Boskovic Inst, Div Mol Med, Lab Funct Genom, HR-10002 Zagreb, Croatia
来源
CURRENT STUDIES OF BIOTECHNOLOGY, VOL IV: IMMUNO-MODULATORY DRUGS | 2005年
关键词
molecular-targeted therapy; tumor suppressor genes; p53; p21WAF1/CIP1; apoptosis; gene therapy; CELL-CYCLE; TUMOR-SUPPRESSOR; IN-VIVO; ANTICANCER AGENTS; GROWTH-INHIBITION; MUTANT P53; APOPTOSIS; ADENOVIRUS; SENESCENCE; P21;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:27 / 36
页数:10
相关论文
共 48 条
[1]  
Atkins JH, 2002, NAT REV DRUG DISCOV, V1, P491, DOI 10.1038/nrd842
[2]   Prospective strategies to enforce selectively cell death in cancer cells [J].
Blagosklonny, MV .
ONCOGENE, 2004, 23 (16) :2967-2975
[3]   P53: An ubiquitous target of anticancer drugs [J].
Blagosklonny, MV .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (02) :161-166
[4]  
Brown JM, 1999, CANCER RES, V59, P1391
[5]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[6]   p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivo [J].
Cardinali, M ;
Jakus, J ;
Shah, S ;
Ensley, JF ;
Robbins, KC ;
Yeudall, WA .
ORAL ONCOLOGY, 1998, 34 (03) :211-218
[7]   Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression:: Implications for carcinogenesis, senescence, and age-related diseases [J].
Chang, BD ;
Watanabe, K ;
Broude, EV ;
Fang, J ;
Poole, JC ;
Kalinichenko, TV ;
Roninson, IB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) :4291-4296
[8]  
Damia G, 2004, CELL CYCLE, V3, P46
[9]   Geldanamycin prevents nuclear translocation of mutant p53 [J].
Dasgupta, G ;
Momand, J .
EXPERIMENTAL CELL RESEARCH, 1997, 237 (01) :29-37
[10]  
DEMONACOS D, 2003, PROG CELL CYCLE RES, V5, P375